Please confirm you are human (Sign Up for free to never see this)
← Back to Search
In Vivo Magnetic Resonance Imaging Of Cell Tropism, Trafficking Mechanism, And Therapeutic Impact Of Human Mesenchymal Stem Cells In A Murine Glioma Model.
Li-Ying Chien, Jong-Kai Hsiao, Szu-Chun Hsu, M. Yao, Chen-Wen Lu, Hon-Man Liu, Yao-Chang Chen, C. Yang, D. Huang
Published 2011 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Stem cells have offered much promise as delivery vehicles for brain tumor therapy, with the development of modalities to track the tumor tropism of stem cells receiving intense focus. Cellular magnetic resonance imaging (MRI) allows serial high-resolution in vivo detection of transplanted stem cells' tropism toward gliomas in the mouse brain once these cells are internally labeled with iron oxide particles, but has been impeded by low labeling efficiencies. In this study, we describe the use of ferucarbotran and protamine (Fer-Pro) complexes for labeling human mesenchymal stem cells (hMSCs) for MRI tracking of glioma tropism in vivo. We found that Fer-Pro was not toxic and was highly efficient for labeling in vitro. Cell labeling with Fer-Pro promoted the migration of hMSCs toward glioma U87MG cells in vitro, which was mediated by stromal-derived factor-1/CXCR4 (SDF-1/CXCR4) signaling. Fer-Pro-labeled hMSCs could migrate specifically toward gliomas in vivo, which was observed with a clinical 1.5-T MRI system. The efficient labeling of Fer-Pro also allowed a tropic mechanism mediated by SDF-1/CXCR4 signaling to be detected by MRI in vivo. Additionally, the potential intrinsic inhibitory effect of hMSCs on glioma progression was estimated simultaneously. This is the first report to have used a clinical MRI modality to simultaneously study the migration, the therapeutic impact on tumors, and above all the trafficking mechanism of bone marrow-derived mesenchymal stem cells from human in a murine glioma xenograft model. The use of Fer-Pro for stem cell labeling may have potential clinical applications in stem cell guided therapy.
This paper references
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking
D. Huang (2005)
Serial in vivo positive contrast MRI of iron oxide‐labeled embryonic stem cell‐derived cardiac precursor cells in a mouse model of myocardial infarction
V. Mani (2008)
Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis
P Symonds (2005)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
A. Nakamizo (2005)
Targeted therapy for malignant: neural stem cells
MS Lesniak (2006)
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.
A. Arbab (2004)
Targeted therapy for malignant glioma: neural stem cells
M. Lesniak (2006)
Neural Progenitor Cell Lines Inhibit Rat Tumor Growth in Vivo
K. Staflin (2004)
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001;19:180e92
P Bianco (2001)
Low and high molecular weight poly ( L - lysine ) s / poly ( L - lysine )DNA complexes initiate mitochondrialmediated apoptosis differently
P Symonds (2006)
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
L. Qiao (2008)
Multilineage potential of adult human mesenchymal stem cells.
M. Pittenger (1999)
: nature , biology , and potential applications
P Bianco (1987)
Low and high molecular weight poly(l‐lysine)s/poly(l‐lysine)–DNA complexes initiate mitochondrial‐mediated apoptosis differently
P. Symonds (2005)
CellularmultiparametricMRI of neural stemcell therapy in a rat gliomamodel
C Brekke (2007)
Glioma classification: a molecular reappraisal.
D. Louis (2001)
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
Stem Cells Not So Stealthy After All
G. Vogel (2002)
Use of ferumoxides for stem cell labeling.
H. Sadek (2008)
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling of with ferumoxides. Blood 2004;104:3410e2
JWM Bulte (2004)
Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells
A. Arbab (2005)
Accelerated stem cell labeling with ferucarbotran and protamine
Daniel Golovko (2009)
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers
A. Friedenstein (1987)
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
Current management of glioblastoma multiforme.
S. Grossman (2004)
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
K. Nakamura (2004)
Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.
A. C. Hunter (2006)
Molecularhurdles inpolyfectiondesignandmechanisticbackground to polycation induced cytotoxicity
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.
D. Huang (2009)
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.
J. Bulte (2004)
Instant MR labeling of stem cells using magnetoelectroporation
P. Walczak (2005)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
A. Khakoo (2006)
Embryonic stem cells. Stem cells not so stealthy after all.
G. Vogel (2002)
In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor
Z. Zhang (2004)
Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
K. S. Aboody (2000)
The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells.
Ying-chun Chen (2010)
Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications
P. Bianco (2001)
Carboxylated Superparamagnetic Iron Oxide Particles Label Cells Intracellularly Without Transfection Agents
V. Mailänder (2007)
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model
C. Brekke (2007)
Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma Model
Mya S. Thu (2009)
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
Genetic Pathways to Glioblastoma
H. Ohgaki (2004)
Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: Cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level
J. Hsiao (2007)
Mesenchymal stem cell: use and perspectives.
A. Tocci (2003)
Stem cell therapies for malignant glioma.
M. Ehtesham (2005)
Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
A. Sonabend (2008)
Gene therapy of experimental brain tumors using neural progenitor cells
S. Benedetti (2000)
Epidemiology of brain tumors
A. Walker (1985)
Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
B. Bull (1975)
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.
M. Ehtesham (2004)
This paper is referenced by
Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy.
Tsai-Hua Chung (2011)
Magnetic Nanoparticles: Its Effect on Cellular Behaviour and Potential Applications
H. Liu (2012)
Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs
Tsai-Hua Chung (2016)
Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles.
C. Wang (2012)
The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.
E. D. Gomes (2018)
The mutual beneficial effect between medical imaging and nanomedicine
Huiting Qiao (2013)
Imaging of human mesenchymal stromal cells: homing to human brain tumors
L. Menon (2011)
The Impact of Metallic Nanoparticles on Stem Cell Proliferation and Differentiation
Ahmed Abdal Dayem (2018)
Identification of Chemoattractive Factors Involved in the Migration of Bone Marrow-Derived Mesenchymal Stem Cells to Brain Lesions Caused by Prions
C.-H. Song (2011)
Stem Cell Labeling and Tracking with Nanoparticles
C. Liang (2013)
Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.
Xihui Gao (2014)
Bidirectional Enhancement of Cell Proliferation Between Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cells and Choroid Plexus in a Cell-Based Therapy Model of Ischemic Stroke
Menq-Rong Wu (2020)
MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma
M. Wu (2018)
Mesenchymal Stem/Stromal Cell Trafficking and Homing
A. H. N. Kamdje (2016)
Magnetic Resonance Imaging Tracking of Ferumoxytol‐Labeled Human Neural Stem Cells: Studies Leading to Clinical Use
M. Gutova (2013)
Clinical Stem Cell Imaging and In vivo Tracking
S. Mirpour (2011)
Novel Positively Charged Nanoparticle Labeling for In Vivo Imaging of Adipose Tissue-Derived Stem Cells
H. Yukawa (2014)
Multimodal magnetic core-shell nanoparticles for effective stem-cell differentiation and imaging.
B. Shah (2013)
Validity of Bone Marrow Stromal Cell Expansion by Animal Serum-Free Medium for Cell Transplantation Therapy of Cerebral Infarct in Rats—A Serial MRI Study
M. Ito (2011)
Superparamagnetic core/shell GoldMag nanoparticles: size-, concentration- and time-dependent cellular nanotoxicity on human umbilical vein endothelial cells and the suitable conditions for magnetic resonance imaging
Mingfu Gong (2015)
Development of Anti-Cancer Stem Cells as Theranostic Agents in the Treatment of Different Cancer Types: An Update
A. Malik (2017)
A unique 19F MRI agent for the tracking of non phagocytic cells in vivo.
S. Moonshi (2018)
Cytotoxicity studies of Fe3O4 nanoparticles in chicken macrophage cells
S. Zhang (2020)
In vivo imaging of insulin‐secreting human pancreatic ductal cells using MRI reporter gene technique: A feasibility study
Menq-Rong Wu (2019)
Estudo de internalização e viabilidade de nanopartículas multimodal para marcação de células-tronco mesenquimais de cordão umbilical humano Study of internalization and viability of multimodal nanoparticles for labeling of human umbilical cord mesenchymal stem cells
Liza Aya (2012)
Nanoparticles and their applications in cell and molecular biology.
E. Wang (2014)
Precise implantation of super-paramagnetic iron oxide (SPIO) nanoparticles in hippocampus with external rotating magnetic field (RMF) produces rapid antidepressent effects in mice
Yao Chi (2019)
Inorganic nanoparticles for the theranostics of cancer
Jyoti Verma (2015)
Imaging Gliomas with Nanoparticle-Labeled Stem Cells
Shuang-Lin Deng (2018)
16 Magnetic Nanoparticles : Its Effect on Cellular Behaviour and Potential Applications
H. Liu (2018)
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
M. Jarzabek (2013)
Identification of valid endogenous control genes for determining gene expression in C6 glioma cell line treated with conditioned medium from adipose-derived stem cell.
I.C. Iser (2015)See more